Quick Answer
STANDARD BIOTOOLS INC. reported Total Revenue of $85.33 million for the year ending 2025.
- STANDARD BIOTOOLS INC. showed a decrease of -6.2% in Total Revenue from 2024 to 2025.
- This data is from STANDARD BIOTOOLS INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2009 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2013: $20.88 million | Q1 2014: $25.72 million | Q2 2014: $27.61 million | Q3 2014: $29.64 million | Q4 2014: $33.49 million | Q1 2015: $26.73 million | Q2 2015: $28.62 million | Q3 2015: $28.64 million | Q4 2015: $30.72 million | Q1 2016: $29.00 million | Q2 2016: $28.17 million | Q3 2016: $22.19 million | Q4 2016: $25.08 million | Q1 2017: $25.53 million | Q1 2017: $25.53 million | Q2 2017: $23.91 million | Q2 2017: $23.91 million | Q3 2017: $24.75 million | Q3 2017: $24.75 million | Q4 2017: $27.75 million | Q4 2017: $27.75 million | Q1 2018: $25.25 million | Q1 2018: $25.25 million | Q2 2018: $26.43 million | Q2 2018: $26.43 million | Q3 2018: $28.96 million | Q4 2018: $32.33 million | Q1 2019: $30.11 million | Q2 2019: $28.20 million | Q3 2019: $26.50 million | Q4 2019: $32.44 million | Q1 2020: $27.62 million | Q2 2020: $26.06 million | Q3 2020: $39.86 million | Q4 2020: $44.61 million | Q1 2021: $32.79 million | Q2 2021: $31.02 million | Q3 2021: $28.50 million | Q1 2022: $26.50 million | Q2 2022: $18.78 million | Q3 2022: $25.65 million | Q1 2023: $25.12 million | Q2 2023: $27.67 million | Q3 2023: $25.37 million | Q1 2024: $45.54 million | Q2 2024: $22.49 million | Q3 2024: $22.09 million | Q1 2025: $40.80 million | Q2 2025: $21.76 million | Q3 2025: $19.55 million.
- Over the full 19 years of available data (2009 to 2025), STANDARD BIOTOOLS INC.'s Total Revenue has grown by 235.8%.
- Historical annual values: Fiscal year 2025: $85.33 million | Fiscal year 2024: $91.01 million | Fiscal year 2023: $106.34 million | Fiscal year 2022: $97.95 million | Fiscal year 2021: $130.58 million | Fiscal year 2020: $138.14 million | Fiscal year 2019: $117.24 million | Fiscal year 2018: $112.96 million | Fiscal year 2017: $101.94 million | Fiscal year 2017: $101.94 million | Fiscal year 2016: $104.45 million | Fiscal year 2016: $104.45 million | Fiscal year 2015: $114.71 million | Fiscal year 2014: $116.46 million | Fiscal year 2013: $71.18 million | Fiscal year 2012: $52.33 million | Fiscal year 2011: $42.87 million | Fiscal year 2010: $33.56 million | Fiscal year 2009: $25.41 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: